Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19
Clinical trial NCT04355676 · WITHDRAWN
Trial details
- NCT number
- NCT04355676
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-30
- Primary completion
- 2020-08-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.